|
|
H. sinensis mycelium inhibits epithelial--mesenchymal transition by inactivating the midkine pathway in pulmonary fibrosis |
Li Lu1, Haiyan Zhu1, Hailin Wang1, Huaping Liang3(), Yayi Hou1,2,4(), Huan Dou1,2,4() |
1. The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing 210093, China 2. Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China 3. State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Daping Hospital, The Army Medical University, Chongqing 400042, China 4. Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China |
|
|
Abstract The medical fungus Hirsutella sinensis has been used as a Chinese folk health supplement because of its immunomodulatory properties. Our previous studies established the antifibrotic action of Hirsutella sinensis mycelium (HSM) in the lung. The epithelial–mesenchymal transition (EMT) is involved in the pathogenesis of idiopathic pulmonary fibrosis. The present study investigates the role of HSM in mediating EMT during the development of pulmonary fibrosis. HSM significantly inhibits bleomycin (BLM)-induced pulmonary fibrosis by blocking the EMT. In addition, the expression levels of midkine are increased in the lungs of the BLM-induced group. Further analysis of the results indicates that the mRNA level of midkine correlated positively with EMT. HSM markedly abrogates the transforming growth factor β-induced EMT-like phenotype and behavior in vitro. The activation of midkine related signaling pathway is ameliorated following HSM treatment, whereas this extract also caused an effective attenuation of the induction of EMT (caused by midkine overexpression) in vitro. Results further confirm that oral medication of HSM disrupted the midkine pathway in vivo. Overall, findings suggest that the midkine pathway and the regulation of the EMT may be considered novel candidate therapeutic targets for the antifibrotic effects caused by HSM.
|
Keywords
epithelial–mesenchymal transition
H. sinensis mycelium
midkine
pulmonary fibrosis
|
Corresponding Author(s):
Huaping Liang,Yayi Hou,Huan Dou
|
Just Accepted Date: 27 September 2020
Online First Date: 12 November 2020
Issue Date: 23 April 2021
|
|
1 |
L Richeldi, HR Collard, MG Jones. Idiopathic pulmonary fibrosis. Lancet 2017; 389(10082): 1941–1952
https://doi.org/10.1016/S0140-6736(17)30866-8
pmid: 28365056
|
2 |
SL Barratt, A Creamer, C Hayton, N Chaudhuri. Idiopathic pulmonary fibrosis (IPF): an overview. J Clin Med 2018; 7(8): E201
https://doi.org/10.3390/jcm7080201
pmid: 30082599
|
3 |
M Funke, T Geiser. Idiopathic pulmonary fibrosis: the turning point is now! Swiss Med Wkly 2015; 145: w14139
https://doi.org/10.4414/smw.2015.14139
pmid: 26024356
|
4 |
ES Kim, GM Keating. Pirfenidone: a review of its use in idiopathic pulmonary fibrosis. Drugs 2015; 75(2): 219–230
https://doi.org/10.1007/s40265-015-0350-9
pmid: 25604027
|
5 |
L Richeldi, RM du Bois, G Raghu, A Azuma, KK Brown, U Costabel, V Cottin, KR Flaherty, DM Hansell, Y Inoue, DS Kim, M Kolb, AG Nicholson, PW Noble, M Selman, H Taniguchi, M Brun, F Le Maulf, M Girard, S Stowasser, R Schlenker-Herceg, B Disse, HR Collard; INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370(22): 2071–2082
https://doi.org/10.1056/NEJMoa1402584
pmid: 24836310
|
6 |
KC Meyer, CA Decker. Role of pirfenidone in the management of pulmonary fibrosis. Ther Clin Risk Manag 2017; 13: 427–437
https://doi.org/10.2147/TCRM.S81141
pmid: 28435277
|
7 |
L Richeldi, V Cottin, KR Flaherty, M Kolb, Y Inoue, G Raghu, H Taniguchi, DM Hansell, AG Nicholson, F Le Maulf, S Stowasser, HR Collard. Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis. Respir Med 2014; 108(7): 1023–1030
https://doi.org/10.1016/j.rmed.2014.04.011
pmid: 24834811
|
8 |
A Hajari Case, P Johnson. Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis. BMJ Open Respir Res 2017; 4(1): e000192
https://doi.org/10.1136/bmjresp-2017-000192
pmid: 28883926
|
9 |
JS Zhu, GM Halpern, K Jones. The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis: part I. J Altern Complement Med 1998; 4(3): 289–303
https://doi.org/10.1089/acm.1998.4.3-289
pmid: 9764768
|
10 |
JS Zhu, GM Halpern, K Jones. The scientific rediscovery of a precious ancient Chinese herbal regimen: Cordyceps sinensis: part II. J Altern Complement Med 1998; 4(4): 429–457
https://doi.org/10.1089/acm.1998.4.429
pmid: 9884180
|
11 |
TT Huang, KY Chong, DM Ojcius, YH Wu, YF Ko, CY Wu, J Martel, CC Lu, HC Lai, JD Young. Hirsutella sinensis mycelium suppresses interleukin-1b and interleukin-18 secretion by inhibiting both canonical and non-canonical inflammasomes. Sci Rep 2013; 3(1): 1374
https://doi.org/10.1038/srep01374
pmid: 23459183
|
12 |
TT Huang, HC Lai, YF Ko, DM Ojcius, YW Lan, J Martel, JD Young, KY Chong. Hirsutella sinensis mycelium attenuates bleomycin-induced pulmonary inflammation and fibrosis in vivo. Sci Rep 2015; 5(1): 15282
https://doi.org/10.1038/srep15282
pmid: 26497260
|
13 |
JH Koh, KW Yu, HJ Suh, YM Choi, TS Ahn. Activation of macrophages and the intestinal immune system by an orally administered decoction from cultured mycelia of Cordyceps sinensis. Biosci Biotechnol Biochem 2002; 66(2): 407–411
https://doi.org/10.1271/bbb.66.407
pmid: 11999417
|
14 |
SL Nordin, S Jovic, A Kurut, C Andersson, A Gela, A Bjartell, M M�rgelin, AI Olin, M Lund, A Egesten. High expression of midkine in the airways of patients with cystic fibrosis. Am J Respir Cell Mol Biol 2013; 49(6): 935–942
https://doi.org/10.1165/rcmb.2013-0106OC
pmid: 23815177
|
15 |
QY Shou, HY Fu, LZ Zhang, YQ Cai, FM Chen, ML Chen. Study on treatment effect and mechanism of Hirsutella sinensis mycelium in idiopathic pulmonary fibrosis in rats. China J Chin Mater Med (Zhongguo Zhong Yao Za Zhi) 2012; 37(23): 3618–3623 (in Chinese)
|
16 |
H Yue, Y Zhao, H Wang, F Ma, F Liu, S Shen, Y Hou, H Dou. Anti-fibrosis effect for Hirsutella sinensis mycelium based on inhibition of mTOR p70S6K phosphorylation. Innate Immun 2017; 23(7): 615–624
https://doi.org/10.1177/1753425917726361
pmid: 28836874
|
17 |
B Chen, HR Cai, S Xue, WJ You, B Liu, HD Jiang. Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways. Respirology 2016; 21(6): 1075–1080
https://doi.org/10.1111/resp.12815
pmid: 27185272
|
18 |
SL O’Beirne, SM Walsh, A Fabre, C Reviriego, JC Worrell, IP Counihan, RV Lumsden, J Cramton-Barnes, JA Belperio, SC Donnelly, D Boylan, J Marchal-Sommé, R Kane, MP Keane. CXCL9 regulates TGF-b1-induced epithelial to mesenchymal transition in human alveolar epithelial cells. J Immunol 2015; 195(6): 2788–2796
https://doi.org/10.4049/jimmunol.1402008
pmid: 26268659
|
19 |
YC Wang, JS Liu, HK Tang, J Nie, JX Zhu, LL Wen, QL Guo. miR221 targets HMGA2 to inhibit bleomycininduced pulmonary fibrosis by regulating TGFb1/Smad3-induced EMT. Int J Mol Med 2016; 38(4): 1208–1216
https://doi.org/10.3892/ijmm.2016.2705
pmid: 27513632
|
20 |
BC Willis, Z Borok. TGF-b-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007; 293(3): L525–L534 doi:10.1152/ajplung.00163.2007
pmid: 17631612
|
21 |
H Kage, Z Borok. EMT and interstitial lung disease: a mysterious relationship. Curr Opin Pulm Med 2012; 18(5): 517–523 doi:10.1097/MCP.0b013e3283566721
pmid: 22854509
|
22 |
X Xiao, C Huang, C Zhao, X Gou, LK Senavirathna, M Hinsdale, P Lloyd, L Liu. Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition. Arch Biochem Biophys 2015; 566: 49–57
https://doi.org/10.1016/j.abb.2014.12.007
pmid: 25524739
|
23 |
H Zhang, M Okamoto, E Panzhinskiy, WM Zawada, M Das. PKCd/midkine pathway drives hypoxia-induced proliferation and differentiation of human lung epithelial cells. Am J Physiol Cell Physiol 2014; 306(7): C648–C658
https://doi.org/10.1152/ajpcell.00351.2013
pmid: 24500281
|
24 |
LT Weckbach, KT Preissner, E Deindl. The role of midkine in arteriogenesis, involving mechanosensing, endothelial cell proliferation, and vasodilation. Int J Mol Sci 2018; 19(9): E2559
https://doi.org/10.3390/ijms19092559
pmid: 30158425
|
25 |
T Masuda, K Maeda, W Sato, T Kosugi, Y Sato, H Kojima, N Kato, T Ishimoto, N Tsuboi, K Uchimura, Y Yuzawa, S Maruyama, K Kadomatsu. Growth factor midkine promotes T-cell activation through nuclear factor of activated T cells signaling and Th1 cell differentiation in lupus nephritis. Am J Pathol 2017; 187(4): 740–751
https://doi.org/10.1016/j.ajpath.2016.12.006
pmid: 28183532
|
26 |
TA Mitsiadis, T Muramatsu, H Muramatsu, I Thesleff. Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic acid and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis. J Cell Biol 1995; 129(1): 267–281
https://doi.org/10.1083/jcb.129.1.267
pmid: 7698992
|
27 |
S Erdogan, K Turkekul, I Dibirdik, O Doganlar, ZB Doganlar, A Bilir, G Oktem. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway. Biomed Pharmacother 2018; 107: 793–805
https://doi.org/10.1016/j.biopha.2018.08.061
pmid: 30142541
|
28 |
FM Vieceli, ME Bronner. Leukocyte receptor tyrosine kinase interacts with secreted midkine to promote survival of migrating neural crest cells. Development 2018; 145(20): dev164046
https://doi.org/10.1242/dev.164046
pmid: 30228102
|
29 |
N Konishi, M Nakamura, S Nakaoka, Y Hiasa, M Cho, H Uemura, Y Hirao, T Muramatsu, K Kadomatsu. Immunohistochemical analysis of midkine expression in human prostate carcinoma. Oncology 1999; 57(3): 253–257
https://doi.org/10.1159/000012039
pmid: 10545795
|
30 |
S Netsu, T Shishido, T Kitahara, Y Honda, A Funayama, T Narumi, S Kadowaki, H Takahashi, T Miyamoto, T Arimoto, S Nishiyama, T Watanabe, CH Woo, Y Takeishi, I Kubota. Midkine exacerbates pressure overload-induced cardiac remodeling. Biochem Biophys Res Commun 2014; 443(1): 205–210
https://doi.org/10.1016/j.bbrc.2013.11.083
pmid: 24291499
|
31 |
SL Nordin, S Jovic, A Kurut, C Andersson, A Gela, A Bjartell, M M�rgelin, AI Olin, M Lund, A Egesten. High expression of midkine in the airways of patients with cystic fibrosis. Am J Respir Cell Mol Biol 2013; 49(6): 935–942
https://doi.org/10.1165/rcmb.2013-0106OC
pmid: 23815177
|
32 |
II Siempos, AM Choi. Midkine: in the middle of the pathogenesis of acute respiratory distress syndrome-associated lung fibrosis? Am J Respir Crit Care Med 2015; 192(3): 271–272
https://doi.org/10.1164/rccm.201506-1084ED
pmid: 26230229
|
33 |
R Zhang, Y Pan, V Fanelli, S Wu, AA Luo, D Islam, B Han, P Mao, M Ghazarian, W Zeng, PM Spieth, D Wang, J Khang, H Mo, X Liu, S Uhlig, M Liu, J Laffey, AS Slutsky, Y Li, H Zhang. Mechanical stress and the induction of lung fibrosis via the midkine signaling pathway. Am J Respir Crit Care Med 2015; 192(3): 315–323
https://doi.org/10.1164/rccm.201412-2326OC
pmid: 25945397
|
34 |
C G�ng�r, H Zander, KE Effenberger, YK Vashist, T Kalinina, JR Izbicki, E Yekebas, M Bockhorn. Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer. Cancer Res 2011; 71(14): 5009–5019
https://doi.org/10.1158/0008-5472.CAN-11-0036
pmid: 21632553
|
35 |
G Zhao, Y Nie, M Lv, L He, T Wang, Y Hou. ERb-mediated estradiol enhances epithelial mesenchymal transition of lung adenocarcinoma through increasing transcription of midkine. Mol Endocrinol 2012; 26(8): 1304–1315
https://doi.org/10.1210/me.2012-1028
pmid: 22669742
|
36 |
Y Huang, MO Hoque, F Wu, B Trink, D Sidransky, EA Ratovitski. Midkine induces epithelial-mesenchymal transition through Notch2/Jak2-Stat3 signaling in human keratinocytes. Cell Cycle 2008; 7(11): 1613–1622
https://doi.org/10.4161/cc.7.11.5952
pmid: 18469519
|
37 |
K Misa, Y Tanino, X Wang, T Nikaido, M Kikuchi, Y Sato, R Togawa, M Tanino, S Tanaka, K Kadomatsu, M Munakata. Involvement of midkine in the development of pulmonary fibrosis. Physiol Rep 2017; 5(16): e13383
https://doi.org/10.14814/phy2.13383
pmid: 28811360
|
38 |
QL Wang, H Wang, SL Zhao, YH Huang, YY Hou. Over-expressed and truncated midkines promote proliferation of BGC823 cells in vitro and tumor growth in vivo. World J Gastroenterol 2008; 14(12): 1858–1865
https://doi.org/10.3748/wjg.14.1858
pmid: 18350623
|
39 |
K Rajasekaran, V Xiong, L Fong, J Gorski, S Malarkannan. Functional dichotomy between NKG2D and CD28-mediated co-stimulation in human CD8+ T cells. PLoS One 2010; 5(9): e12635
https://doi.org/10.1371/journal.pone.0012635
pmid: 20844584
|
40 |
A Gardner, AJ Fisher, C Richter, GE Johnson, EJ Moisey, M Brodlie, C Ward, A Krippner-Heidenreich, DA Mann, LA Borthwick. The critical role of TAK1 in accentuated epithelial to mesenchymal transition in obliterative bronchiolitis after lung transplantation. Am J Pathol 2012; 180(6): 2293–2308
https://doi.org/10.1016/j.ajpath.2012.02.022
pmid: 22525462
|
41 |
R Tian, Y Zhu, J Yao, X Meng, J Wang, H Xie, R Wang. NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis. Exp Cell Res 2017; 357(2): 328–334
https://doi.org/10.1016/j.yexcr.2017.05.028
pmid: 28591554
|
42 |
S Vyas-Read, W Wang, S Kato, J Colvocoresses-Dodds, NH Fifadara, TW Gauthier, MN Helms, DP Carlton, LA Brown. Hyperoxia induces alveolar epithelial-to-mesenchymal cell transition. Am J Physiol Lung Cell Mol Physiol 2014; 306(4): L326–L340
https://doi.org/10.1152/ajplung.00074.2013
pmid: 24375795
|
43 |
N Suzuki, Y Shibata, T Urano, T Murohara, T Muramatsu, K Kadomatsu. Proteasomal degradation of the nuclear targeting growth factor midkine. J Biol Chem 2004; 279(17): 17785–17791
https://doi.org/10.1074/jbc.M310772200
pmid: 14970216
|
44 |
SH Phan. The myofibroblast in pulmonary fibrosis. Chest 2002; 122(6 Suppl): 286S–289S
https://doi.org/10.1378/chest.122.6_suppl.286S
pmid: 12475801
|
45 |
H Zhao, QQ Wu, LF Cao, HY Qing, C Zhang, YH Chen, H Wang, RY Liu, DX Xu. Melatonin inhibits endoplasmic reticulum stress and epithelial-mesenchymal transition during bleomycin-induced pulmonary fibrosis in mice. PLoS One 2014; 9(5): e97266
https://doi.org/10.1371/journal.pone.0097266
pmid: 24818755
|
46 |
AS Marudamuthu, YP Bhandary, SK Shetty, J Fu, V Sathish, Y Prakash, S Shetty. Role of the urokinase-fibrinolytic system in epithelial-mesenchymal transition during lung injury. Am J Pathol 2015; 185(1): 55–68
https://doi.org/10.1016/j.ajpath.2014.08.027
pmid: 25447049
|
47 |
SY Kyung, DY Kim, JY Yoon, ES Son, YJ Kim, JW Park, SH Jeong. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. BMC Pharmacol Toxicol 2018; 19(1): 13
https://doi.org/10.1186/s40360-018-0204-7
pmid: 29609658
|
48 |
KK Kim, MC Kugler, PJ Wolters, L Robillard, MG Galvez, AN Brumwell, D Sheppard, HA Chapman. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006; 103(35): 13180–13185
https://doi.org/10.1073/pnas.0605669103
pmid: 16924102
|
49 |
R Kalluri, EG Neilson. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112(12): 1776–1784
https://doi.org/10.1172/JCI200320530
pmid: 14679171
|
50 |
H Tanjore, XC Xu, VV Polosukhin, AL Degryse, B Li, W Han, TP Sherrill, D Plieth, EG Neilson, TS Blackwell, WE Lawson. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 2009; 180(7): 657–665
https://doi.org/10.1164/rccm.200903-0322OC
pmid: 19556518
|
51 |
KK Kim, Y Wei, C Szekeres, MC Kugler, PJ Wolters, ML Hill, JA Frank, AN Brumwell, SE Wheeler, JA Kreidberg, HA Chapman. Epithelial cell a3b1 integrin links b-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 2009; 119(1): 213–224
pmid: 19104148
|
52 |
Y Huang, MO Hoque, F Wu, B Trink, D Sidransky, EA Ratovitski. Midkine induces epithelial-mesenchymal transition through Notch2/Jak2-Stat3 signaling in human keratinocytes. Cell Cycle 2008; 7(11): 1613–1622
https://doi.org/10.4161/cc.7.11.5952
pmid: 18469519
|
53 |
K Misa, Y Tanino, X Wang, T Nikaido, M Kikuchi, Y Sato, R Togawa, M Tanino, S Tanaka, K Kadomatsu, M Munakata. Involvement of midkine in the development of pulmonary fibrosis. Physiol Rep 2017; 5(16): e13383
https://doi.org/10.14814/phy2.13383
pmid: 28811360
|
54 |
F Liu, AM Gomez Garcia, FL Meyskens Jr. NADPH oxidase 1 overexpression enhances invasion via matrix metalloproteinase-2 and epithelial-mesenchymal transition in melanoma cells. J Invest Dermatol 2012; 132(8): 2033–2041
https://doi.org/10.1038/jid.2012.119
pmid: 22513785
|
55 |
D Kesanakurti, D Maddirela, YK Banasavadi-Siddegowda, TH Lai, Z Qamri, NK Jacob, D Sampath, S Mohanam, B Kaur, VK Puduvalli. A novel interaction of PAK4 with PPARg to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma. Oncogene 2017; 36(37): 5309–5320
https://doi.org/10.1038/onc.2016.261
pmid: 28534509
|
56 |
SJ Das, FJ Lovicu, EJ Collinson. Nox4 plays a role in TGF-b-dependent lens epithelial to mesenchymal transition. Invest Ophthalmol Vis Sci 2016; 57(8): 3665–3673
https://doi.org/10.1167/iovs.16-19114
pmid: 27403995
|
57 |
YK Rao, SH Fang, YM Tzeng. Evaluation of the anti-inflammatory and anti-proliferation tumoral cells activities of Antrodia camphorata, Cordyceps sinensis, and Cinnamomum osmophloeum bark extracts. J Ethnopharmacol 2007; 114(1): 78–85
https://doi.org/10.1016/j.jep.2007.07.028
pmid: 17822865
|
58 |
YF Ko, JC Liau, CS Lee, CY Chiu, J Martel, CS Lin, SF Tseng, DM Ojcius, CC Lu, HC Lai, JD Young. Isolation, culture and characterization of Hirsutella sinensis mycelium from Caterpillar fungus fruiting body. PLoS One 2017; 12(1): e0168734
https://doi.org/10.1371/journal.pone.0168734
pmid: 28046129
|
59 |
A Datta, GA Kim, JM Taylor, SF Gugino, KN Farrow, PT Schumacker, SK Berkelhamer. Mouse lung development and NOX1 induction during hyperoxia are developmentally regulated and mitochondrial ROS dependent. Am J Physiol Lung Cell Mol Physiol 2015; 309(4): L369–L377
https://doi.org/10.1152/ajplung.00176.2014
pmid: 26092998
|
60 |
F Zanetti, M Giacomello, Y Donati, S Carnesecchi, M Frieden, C Barazzone-Argiroffo. Nicotine mediates oxidative stress and apoptosis through cross talk between NOX1 and Bcl-2 in lung epithelial cells. Free Radic Biol Med 2014; 76: 173–184
https://doi.org/10.1016/j.freeradbiomed.2014.08.002
pmid: 25151121
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|